Cargando…
Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis
Methotrexate (MTX) remains the cornerstone therapy for patients with rheumatoid arthritis (RA), with well-established safety and efficacy profiles and support in international guidelines. Clinical and radiologic results indicate benefits of MTX monotherapy and combination with other agents, yet pati...
Autores principales: | Bello, Alfonso E, Perkins, Elizabeth L, Jay, Randy, Efthimiou, Petros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386601/ https://www.ncbi.nlm.nih.gov/pubmed/28435338 http://dx.doi.org/10.2147/OARRR.S131668 |
Ejemplares similares
-
Screening Optimization of Latent Tuberculosis Infection in Rheumatoid Arthritis Patients
por: Mehta, Bella, et al.
Publicado: (2015) -
Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs
por: Kukar, Manil, et al.
Publicado: (2009) -
Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012) -
Markers of Treatment Response to Methotrexate in Rheumatoid Arthritis: Where Do We Stand?
por: Halilova, Karina I., et al.
Publicado: (2012) -
Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022)